2,5,8,11,14,17,20,23,26,29,32,35,38,41,44,47-Hexadecaoxanonatetracontan-49-amine

Catalog No. :
ACTLGO387
CAS No. :
907577-50-8
Molecular Formula :
C33H69NO16
Molecular Weight :
735.91

IUPAC Name:2,5,8,11,14,17,20,23,26,29,32,35,38,41,44,47-hexadecaoxanonatetracontan-49-amine

2,5,8,11,14,17,20,23,26,29,32,35,38,41,44,47-Hexadecaoxanonatetracontan-49-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$105.00Login to see priceIn stockInquiry
100mg95%$139.00Login to see priceIn stockInquiry
250mg95%$209.00Login to see priceIn stockInquiry
1g95%$418.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,5,8,11,14,17,20,23,26,29,32,35,38,41,44,47-Hexadecaoxanonatetracontan-49-amine
IUPAC Name2,5,8,11,14,17,20,23,26,29,32,35,38,41,44,47-hexadecaoxanonatetracontan-49-amine
MDL No.MFCD31656924
Molecular FormulaC33H69NO16
Molecular Weight735.91
SMILESCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCN
InChI KeyAZTFEVBTZHBNCX-UHFFFAOYSA-N
SynonymMPEG16-NH2;mPEG16-NH2;MeO-16eg-NH2;mPEG??-NH?;mPEG16-NH2/3,6,9,12,15,18,21,24,27,30,33,36,39,42,45,48-Hexadecaoxanonatetracontan-1-amine;3,6,9,12,15,18,21,24,27,30,33,36,39,42,45,48-Hexadecaoxanonatetracontan-1-amine;2,5,8,11,14,17,20,23,26,29,32,35,38,41,44,47-hexadecaoxanonatetracontan-49-amine
CAS No.907577-50-8
PubChem CID102484782

Synthetic Route by SureRoute

1. ACTLGO387 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKRGU634 route compound structure diagram
    ACKRGU6342564606-73-9 In Stock
  2. Then
  3. ACTLGO387 route product structure diagram
    ACTLGO387907577-50-8 In Stock
Inquiry

2. ACTLGO387 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTLGO387 route product structure diagram
    ACTLGO387907577-50-8 In Stock
Inquiry

Comments (0)